Home / Denmark / Novozymes A/S
Novozymes A/S
Short position disclosed on July 28, 2026.
Evolution of the disclosed total
November 1, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AQR Capital Management, LLC | 0.79% | new | July 28, 2026 |
In the United States NVZMF (OTC): 881,571 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Novozymes A/S Titelia
Get the moves on Novozymes A/S by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 10, 2017 | Marshall Wace LLP | 0.60% | April 10, 2017 |
| April 4, 2017 | AQR Capital Management, LLC | 1.10% | April 4, 2017 |
| March 8, 2017 | Marshall Wace LLP | 0.58% | March 8, 2017 |
| March 3, 2017 | AQR Capital Management, LLC | 1.00% | March 3, 2017 |
| February 23, 2017 | Marshall Wace LLP | 0.60% | February 23, 2017 |
| February 23, 2017 | Citadel Europe LLP | 0.48% | February 23, 2017 |
| February 17, 2017 | Marshall Wace LLP | 0.52% | February 17, 2017 |
| February 13, 2017 | AQR Capital Management, LLC | 0.90% | February 13, 2017 |
| February 1, 2017 | AQR Capital Management, LLC | 0.80% | February 1, 2017 |
| January 20, 2017 | Citadel Europe LLP | 0.50% | January 20, 2017 |
| January 12, 2017 | AQR Capital Management, LLC | 0.70% | January 12, 2017 |
| January 6, 2017 | Citadel Europe LLP | 0.49% | January 6, 2017 |
| December 13, 2016 | AQR Capital Management, LLC | 0.60% | December 13, 2016 |
| November 13, 2016 | Citadel Europe LLP | 0.50% | November 13, 2016 |
| November 11, 2016 | AQR Capital Management, LLC | 0.50% | November 11, 2016 |
| June 18, 2014 | AQR Capital Management, LLC | 0.41% | June 18, 2014 |
| August 15, 2013 | AKO Capital LLP | 0.45% | August 15, 2013 |
| August 14, 2013 | AKO Capital LLP | 0.55% | August 14, 2013 |
| August 9, 2013 | AKO Capital LLP | 0.69% | August 9, 2013 |
| July 15, 2013 | AKO Capital LLP | 0.70% | July 15, 2013 |
| July 11, 2013 | AKO Capital LLP | 0.64% | July 11, 2013 |
| July 9, 2013 | AKO Capital LLP | 0.52% | July 9, 2013 |
| June 19, 2013 | AQR Capital Management, LLC | 0.59% | June 19, 2013 |
| November 12, 2012 | AQR Capital Management, LLC | 0.52% | November 12, 2012 |
| November 1, 2012 | AQR Capital Management, LLC | 0.60% | November 1, 2012 |
Download 225 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Denmark
- Zealand Pharma A/S 6.33% of the capital sold short
- GN Store Nord A/S 5.56% of the capital sold short
- Netcompany Group A/S 4.49% of the capital sold short
- Ambu A/S 2.58% of the capital sold short
- Pandora A/S 1.89% of the capital sold short
- Carlsberg A/S 1.44% of the capital sold short
- Bavarian Nordic A/S 1.29% of the capital sold short
- Matas A/S 1.08% of the capital sold short
- A.P. Møller - Mærsk A/S 1.04% of the capital sold short
- Coloplast A/S 1.01% of the capital sold short
- Vestas Wind Systems A/S 1.01% of the capital sold short
- Rockwool A/S 1.00% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Novozymes A/S, source Finanstilsynet, data as at July 28, 2026, https://www.quivad.com/action/novozymes-a-s?page=5